A series of prominent initial public offerings have been cancelled, deferred, or paused during 2026. This trend emerges as corporate issuers confront heightened market instability and a strong demand from investors for more conservative pricing. These setbacks are testing expectations for a durable recovery in international equity capital markets, forcing businesses to re-evaluate how and when they raise public capital.
Among the most recent casualties is the Australian artificial intelligence data centre firm Firmus, which is backed by Nvidia. The company recently abandoned its listing plans, which would have represented the second-largest stock market debut in Australia. Firmus had targeted a valuation of roughly $30.6 billion but chose to withdraw due to turbulent trading conditions. It now intends to seek private capital while keeping alternative listing paths open.
Similar challenges have emerged across the United States financial markets. Wall Street brokerage Clear Street cancelled its planned listing in February after previously lowering its fundraising goals and delaying the process. In September, smart-ring producer Oura deferred its American listing, which aimed to raise up to $2.2 billion and achieve a valuation of up to $15 billion. Nuclear technology firm Holtec Nuclear also withdrew its American offering that same month, citing weak investor sentiment in both the broader equity markets and the nuclear sector.
The insurance and manufacturing sectors have not been spared from these delays. Bamboo Insurance Services postponed its American listing in late September. The firm had hoped to raise up to $700 million by selling 35 million shares, targeting a valuation exceeding $3 billion. Around the same time, advanced materials specialist Amaero put its plans to sell 7.5 million shares on hold, choosing to wait for more supportive market conditions before proceeding.
In Europe, the Franco-German military equipment manufacturer KNDS paused its listing in July. The maker of Leopard 2 tanks was expected to achieve a valuation of approximately 15 billion euros, equivalent to $16.84 billion. Despite the strategic prominence of the defence sector, the company decided to wait for better market conditions, proving that long-term industry growth does not guarantee immediate investor enthusiasm.
Commodity and financial technology firms are also adjusting their timelines. CopperTech Metals deferred its American listing in June due to instability in the copper equities sector, pausing plans to raise $423.5 million at a valuation of up to $3.57 billion. In India, the Walmart-backed digital payments firm PhonePe paused its listing plans in mid-March. PhonePe had been aiming for a valuation between $9 billion and $10.5 billion but paused due to international geopolitical friction and capital market swings.
These widespread delays demonstrate that a recovery in global listing activity is highly dependent on pricing flexibility. Corporate boards are increasingly forced to choose between accepting lower valuations or turning to private funding networks. For chief financial officers, navigating this environment requires balancing immediate capital requirements against highly sensitive public market sentiment across different regions.
Key numbers
- Firmus targeted valuation: $30.6 billion
- Oura maximum fundraising target: $2.2 billion
- Bamboo Insurance maximum valuation: $3 billion
- KNDS expected valuation: 15 billion euros
- PhonePe targeted valuation: $9 billion to $10.5 billion
What a board might note
- Should the board re-evaluate the timing of any planned public listings in light of the valuation challenges faced by firms like PhonePe and Firmus in 2026?
- Does the finance team need to explore alternative private-market funding sources as a backup, similar to the strategy adopted by Firmus?
- How do current market volatility levels affect the valuation models of our industry peers, such as those seen in the defence or technology sectors?
Source: Economic Times Markets, 9 October 2026. This is a summary of a news report, published as general information. It is not legal, tax or investment advice.
This article is journalism and commentary. It is not a recommendation to buy or sell any security, and it is not professional advice. Read the full disclaimer.
